How AI Helps Solve the Challenges Facing SMB Pharmaceutical Companies - Coruzant Technologies

COVID-19 ushered in major shifts in the way that healthcare professionals (HCPs) interact with life sciences companies, but how have emerging biopharma companies adapted to this new reality? The core challenges small- to mid-sized (SMB) companies face -- limited resources and overburdened staff tasked with a wide span of responsibilities -- have not changed. Yet suddenly, there is growing demand for advanced technology solutions that empower leaner commercial teams to reach more HCPs efficiently. The life sciences industry has been trying to find the right ratio of sales reps to HCPs for decades. Today, there are about 60,000 pharmaceutical sales reps in the U.S., down from 100,000 in the mid-2000s.